PPMA


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia.
Related to PPMA: PPMS, PMMA

PPMA

atrophy

(a'tro-fe) [ ¹an- + -trophy]
1. A decrease in size of an organ or tissue; wasting. Atrophy may result from death and resorption of cells, diminished cellular proliferation, pressure, ischemia, malnutrition, decreased activity, or hormonal changes.
2. To degenerate; lose size, strength, or vitality. atrophic (a?tro'fik, trof'ik), adjective

brown atrophy

Atrophic tissue that is yellowish-brown rather than its normal color. It is seen principally in the heart and liver of the aged. The pigmentation is due to the presence of lipofuscin, the “wear and tear” pigment that may be associated with aging. Its presence in tissue is a sign of injury from free radicals.
See: lipofuscin; free radical

compression atrophy

Decrease in size, function, or physiologic activity of a body part due to constant pressure.

correlated atrophy

Atrophy of a part following destruction of a correlated part, e.g., of a nerve that supplies a muscle.

Cruveilhier atrophy

Spinal muscular atrophy.

denervation atrophy

Atrophy caused by inhibition of a motor nerve.

disuse atrophy

Partial or complete atrophy of a body part or tissue from immobilization or failure to move a body part.

group atrophy

A change in the appearance of muscle fibers that have lost their nerve supply. It is marked by an increase in the size of the motor unit and a decrease in the fibers within to a uniformly small size.

macular atrophy

Anetoderma.

microvillous atrophy

Microvillus inclusion disease.

multiple systems atrophy

A neurological syndrome marked by Parkinson disease, autonomic failure (loss of sweating, urinary incontinence, dizziness or syncope on arising, miosis), and ataxia.

muscular atrophy

Atrophy of muscle tissue, esp. due to lack of use or denervation.

myelopathic atrophy

Muscular atrophy resulting from a lesion of the spinal cord.

myotonic atrophy

Myotonia congenita.

olivopontocerebellar atrophy

A disease characterized by degeneration of neurons in the cerebellum, pons, and inferior olives of the brain, typically resulting in ataxia.

optic atrophy

Atrophy of the optic disk as a result of degeneration of the optic nerve.

pathological atrophy

Atrophy that results from the effects of disease processes.

peroneal muscular atrophy

Charcot-Marie-Tooth disease.

physiological atrophy

Atrophy caused by the normal aging processes in the body. Examples are atrophy of embryonic structures; atrophy of childhood structures on reaching maturity, as the thymus; atrophy of structures in cyclic phases of activity, as the corpus luteum; atrophy of structures following cessation of functional activity, as the ovary and mammary glands; and atrophy of structures with aging.

postmenopausal vaginal atrophy

Drying and shrinking of the vaginal tissues, related to the hormonal changes associated with menopause. Menopausal women who continue to engage in sexual intercourse during and following menopause have less vaginal atrophy than do those women who become sexually inactive. See: hormone replacement therapy

postpoliomyelitis muscular atrophy

Abbreviation: PPMA
Postpolio syndrome.

progressive hemifacial atrophy

A rare disorder usually affecting females, in which cheek tissues on one side of the face gradually waste or deteriorate. There is no treatment. The disease is often associated with local hair loss and may be accompanied by seizures or trigeminal neuralgia. The progression usually lasts between 2 and 10 years but then enters a stable phase, at which time cosmetic surgery may be possible.
Synonym: Parry-Romberg syndrome

progressive muscular atrophy

Spinal muscular atrophy.

spinal muscular atrophy

An autosomal recessive disorder in which motor neurons in the spinal cord die, leading to muscle paralysis. There are three types. Type 1 usually is fatal by age 4; the cause of death is respiratory paralysis. Types 2 and 3 are slower to progress. Treatments aim to prevent nutritional deficiencies, orthopedic deformities, and respiratory infections. Synonym: Aran-Duchenne disease; Hoffmann atrophy; progressive muscular atrophy; Werdnig-Hoffmann disease; wasting palsy; wasting paralysis

trophoneurotic atrophy

Atrophy due to disease of the nerves or nerve centers supplying the affected muscles.

unilateral facial atrophy

Progressive atrophy of one side of the facial tissues.

urogenital atrophy

Atrophic vaginitis.

Patient discussion about PPMA

Q. Help for/with post-polio problems

A. Clemon -you'll have to be more specific on what kind of help do you ask for. you seek info? seek other people suffering from post-polio? what?
all i can do is give you a good link about it with some info..hope that what you look for:
http://www.post-polio.org/edu/pabout.html

More discussions about PPMA
References in periodicals archive ?
For PPMA at 40[degrees]C and PBMA at 25[degrees]C and 40[degrees]C, there are three inflection pressures detected because of previous observations of two minimum compressibility values.
Figure 5 shows the pressure-volume-temperature dependency data of composites as well as that of PPMA.
But in the past pharma bureau was representing multinational foreign companies and PPMA the local companies.
He is also the Chairman of PPMA, Sindh and Balochistan Region for the year 1992-93.
The restriction on expenses on promotion of drugs be removed totally or if at all the government is determined to fix it, it shall be done on a scale according to turnover of companies in consultation with PPMA.
Shaikh Kaiser Waheed Chairman PPMA shared that since during last 04 years tenure of present government tremendous development has been done in drug regulatory system of Pakistan and we are witnessing paradigm shift in working of DRAP.
He expressed the hope that the PPMA delegations who were holding meetings with the federal government will resolve this matter.
Patients in this country the PPMA Chairman said would be ultimate sufferers if the govt further persisted with its irrational price control policy as locally manufactured medicines with affordable prices used for treating common diseases would no longer be available in the market.
The PPMA Show 2014 reaffirmed its status as the UK's premier free-to-attend complete production line event for processing and packaging machinery, as 8,190 visitors took to the NEC for its 27th show.
PPMA also manages the 20% loan component of the $900 million Tuscany CDO transaction.
A memorandum of understanding (MoU) was also signed between MediBank Trust, Rotary Club, PPMA and Coca Cola.
The PPMA officials said that Drug Regulatory Authority of Pakistan (DRAP) should be made autonomous in reality, being the State's regulator for Pharma industry and related market issues.